Surgical interventions for focal progression of gastrointestinal stromal tumors under imatinib therapy.


9548 Background: Although Imatinib has shown high activity oin advanced gastrointestinal stromal tumors (GIST), secondary resistance appears as focal or systemic progressions during chronic therapy. At present, there are limited therapeutic options for Imatinib-resistant GIST. This retrospective study examines the safety and short-term outcomes of surgical… (More)


  • Presentations referencing similar topics